Overview

A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

Status:
Completed

Trial end date:
2000-09-01

Target enrollment:

Participant gender:

Summary

A study to compare the conversion to Prograf® (tacrolimus) to the continuation of cyclosporine in patients at risk for chronic renal allograft failure

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Inc

Treatments:

Cyclosporine
Cyclosporins
Tacrolimus